EEG tests and EEG monitoring are currently underused when it comes to identifying common diseases and performing neurological assessments in hospital patients, particularly in the United States and Canada. The expanded use of EEG can assist clinicians in making an accurate diagnosis, neurological assessment, or prognosis in patients.
Read MorePsychogenic non-epileptic seizures are common and have a wide variety of symptoms, but can often be misdiagnosed and misunderstood.
Read MoreCortiCare is recognized for its commitment to quality patient care and has earned The Joint Commission’s Gold Seal of Approval®
Read MoreTH in the setting of global ischemic injury to the brain is a treatment that benefits from EEG monitoring in adult, pediatric, and neonatal patients.
Read MoreEEG plays an important role in inclusion/exclusion criteria for safety and efficacy evaluations and as biomarkers in clinical trials. Given the heterogeneity of understanding of the strengths and the limitations of EEG in this context, we provide a brief commentary to inform drug sponsors, contract research organizations, and academic partners on some of the questions to consider.
Read MoreFind out how CortiCare is evolving to meet the anticipated demand and market growth going forward into 2021 and beyond. A recent article in Healthcare Tech Outlook by Jeff Kuznia, Director of Marketing at CortiCare, summarizes the company’s multipronged approach to addressing the EEG service needs of its customers and the goal of improving patient […]
Read MoreDecember 28, 2020 CortiCare was recently named one of the top 10 companies in the forefront of ambulatory care by Healthcare Tech Outlook magazine – addressing the need for in-home ambulatory EEG. For more than 12 years CortiCare has been delivering top-quality ambulatory EEG studies and in the last two years alone has grown to […]
Read MoreThe role for EEG evaluation and monitoring in the ED is well documented, though … there are challenges to obtaining an EEG recording and having it accurately read in a timely manner.
Read MoreReports from Wuhan and Lombardy early in this pandemic indicated that COVID-19 has a significant impact on the brain. In the acute period of SARS-CoV-2 infection, 34.6 % patients were observed to have neurological symptoms including stroke, headache, and seizures. Basic science studies on mechanism of viral entry and vascular involvement have corroborated these observations […]
Read MoreLong-term EEG studies can take days or weeks to schedule and complete, and studies taking place in the Epilepsy Monitoring Unit (EMU) come with increased risk in today’s circumstances. The COVID-19 pandemic has tightened restrictions in hospitals everywhere. For many patients, (in particular, those who only require scalp EEGs and are not having their antiepileptic […]
Read More